1. Pink Sheet
  2. >>Geography
  3. >>Europe

EU Prepares To Reveal Pharma Strategy

Ambitious Proposals Are Due Out Next Week; Medicine Shortages Report Is Also On The Cards

 
• By Ian Schofield

The EU has ambitious plans for dealing with future health crises, bolstering needs-led innovation, improving access to medicines, and tackling drug shortages.

European Union flag with covid-19 coronavirus in background
Future health threats are a key focus for EU • Source: Shutterstock

The European Commission will unveil its long-awaited EU pharmaceutical strategy on 24 November in an effort to improve access to affordable medicines and “harness the benefits of digital and emerging science and technology.” 

The strategy will address both short-term challenges related to COVID-19 “and of course longer-term challenges linked to unmet medical needs, strategic autonomy and sustainable health care systems,” EU health commissioner...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

How Pharma Companies Can Mitigate The Impact Of US Tariffs On The Supply Chain

 
• By Ewan Townsend

If US tariffs on pharmaceutical supply chain products come into force they could be disruptive for companies. Ewan Townsend, of the international law firm Arnold & Porter, explains how companies can mitigate issues through negotiating with suppliers and reallocating tariff responsibilities.

EMA Touts Faster Global Post-Approval Changes Via Regulatory Reliance

 
• By Eliza Slawther

The European Medicines Agency says that a regulatory reliance pilot that it is supporting to speed up assessments of post-approval changes appears to be accelerating evaluation timelines in non-EU countries.

UK And US Regulators In Sync On RWD External Control Arms

 
• By Vibha Sharma

The UK regulator’s draft guideline on the use of external control arms based on real-world data reflects concepts similar to those outlined by the US Food and Drug Administration.

New EU Approvals

 
• By Neena Brizmohun

The Pink Sheet's list of EU centralized approvals of new active substances has been updated to include two new products, one of which is Vyjuvek, Krystal Biotech's advanced therapy for treating dystrophic epidermolysis bullosa.

More from Geography